Affiliations 

  • 1 Key Laboratory of Industrial Biotechnology of MOE, School of Biotechnology, Jiangnan University, Wuxi 214122, China
  • 2 Beijing Key Laboratory of Lignocellulosic Chemistry, Beijing Forestry University, Beijing 100083, China
  • 3 Department of Biomedical, Chemical and Environmental Engineering, University of Cincinnati, Cincinnati, OH 45221, USA
  • 4 Department of Materials Engineering, Isfahan University of Technology, Isfahan 84156-83111, Iran
  • 5 Department of Chemical and Environmental Engineering, Faculty of Engineering, University of Nottingham Malaysia, 43500 Semenyih, Malaysia
  • 6 Key Laboratory of Industrial Biotechnology of MOE, School of Biotechnology, Jiangnan University, Wuxi 214122, China. Electronic address: fubaosun@jiangnan.edu.cn
Bioresour Technol, 2023 Jan;368:128356.
PMID: 36414144 DOI: 10.1016/j.biortech.2022.128356

Abstract

The valorization of organosolv pretreatment (OP) is a required approach to the industrialization of the current enzyme-mediated lignocellulosic biorefinery. Recent literature has demonstrated that the solvolysis happening in the OP can modify the soluble components into value-added active compounds, namely organosolv modified lignin (OML) and organosolv modified sugars (OMSs), in addition to protecting them against excessive degradation. Among them, the OML is coincidental with the "lignin-first" strategy that should render a highly reactive lignin enriched with β-O-4 linkages and less condensed structure by organosolv grafting, which is desirable for the transformation into phenolic compounds. The OMSs are valuable glycosidic compounds mainly synthesized by trans-glycosylation, which can find potential applications in cosmetics, foods, and healthcare. Therefore, a state-of-the-art OP holds a big promise of lowering the process cost by the valorization of these active compounds. Recent advances in organosolv modified components are reviewed, and perspectives are made for addressing future challenges.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.